Rocket


Overview
Financials
News + Filings
Key Docs
Insiders

 
 

Y-mAbs Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-17Dec-31-16
Revenues14.313.9
            Revenue growth3.3% 
Cost of goods sold19.217.0
Gross profit-4.9-3.2
            Gross margin-34.5%-23.0%
General and administrative4.93.2
EBIT-19.2-17.0
            EBIT margin-134.5%-123.0%
Pre-tax income-19.2-17.1
Income taxes0.00.0
            Tax rate0.0%0.0%
Net income0.00.0
            Net margin-0.1%-0.1%
 
Diluted EPS($0.99)($1.21)
Shares outstanding (diluted)0.00.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2018 | Contact Us | Data Disclaimer | Terms of Use | Privacy